This article is part of the supplement: The Third International Symposium on the Molecular Biology of Breast Cancer
Clinical outcome for BRCA1 and BRCA2 mutation carriers after contralateral prophylactic mastectomy
Breast Cancer Research 2005, 7(Suppl 2):P1.09 doi:10.1186/bcr1096
No comments have yet been made on this article.